Coeurative is a biotechnology company that develops and creates curative strategies for diseases related to cellular hypoxia.
Coeurative has raised $300K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Coeurative is headquartered in Roanoke, United States.
Coeurative is a biotechnology company that develops and creates curative strategies for diseases related to cellular hypoxia.
Coeurative is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Coeurative — Funding & Investors." VCBacked, October 10, 2023, https://www.vcbacked.co/company/coeurative. Accessed August 17, 2026.
VCBacked. (2023). Coeurative — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/coeurative
{{cite web |title=Coeurative — Funding & Investors |url=https://www.vcbacked.co/company/coeurative |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated